510(k) K252978

ScioCardio ECG Analysis Platform by Synergen Technology Labs, LLC — Product Code DQK

K252978 is an FDA 510(k) premarket notification submitted by Synergen Technology Labs, LLC for the device "ScioCardio ECG Analysis Platform". The FDA issued a decision of Substantially Equivalent on July 9, 2026. The device falls under product code DQK (Computer, Diagnostic, Programmable), a Class II device regulated under 21 CFR 870.1425. Synergen Technology Labs, LLC has at least 1 other 510(k) clearance on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
July 9, 2026
Date Received
September 17, 2025
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Computer, Diagnostic, Programmable
Device Class
Class II
Regulation Number
870.1425
Review Panel
CV
Submission Type